Uddin Taher, Aktar Amena, Xu Peng, Johnson Russell A, Rahman M Arifur, Leung Daniel T, Afrin Sadia, Akter Aklima, Alam Mohammad Murshid, Rahman Atiqur, Chowdhury Fahima, Khan Ashraful I, Bhuiyan Taufiqur Rahman, Bufano Meagan K, Rashu Rasheduzzaman, Yu Yanan, Wu-Freeman Ying, Harris Jason B, LaRocque Regina C, Charles Richelle C, Kováč Pavol, Calderwood Stephen B, Ryan Edward T, Qadri Firdausi
Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh; NIDDK, LBC, National Institutes of Health, Bethesda, Maryland; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts; Departments of Medicine and Pediatrics, Harvard Medical School, Boston, Massachusetts; Department of Biochemistry and Molecular Biology, University of Dhaka, Bangladesh; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts.
Am J Trop Med Hyg. 2014 May;90(5):873-81. doi: 10.4269/ajtmh.13-0498. Epub 2014 Mar 31.
Protective immunity to cholera is serogroup specific, and serogrouping is defined by the O-specific polysaccharide (OSP) of lipopolysaccharide (LPS). We characterized OSP-specific immune responses in adult recipients of an oral killed cholera vaccine (OCV WC-rBS) and compared these with responses in patients with cholera caused by Vibrio cholerae O1 Ogawa. Although vaccinees developed plasma immunoglobulin G (IgG), IgM, IgA antibody and antibody secreting cell (ASC, marker of mucosal response) to Ogawa OSP and LPS 7 days after vaccination, responses were significantly lower than that which occurred after cholera. Similarly, patients recovering from cholera had detectable IgA, IgM, and IgG memory B cell (MBC) responses against OSP and LPS on Day 30 and Day 90, whereas vaccinees only developed IgG responses to OSP 30 days after the second immunization. The markedly lower ASC and MBC responses to OSP and LPS observed among vaccinees might explain, in part, the lower protection of an OCV compared with natural infection.
霍乱的保护性免疫具有血清群特异性,血清群是由脂多糖(LPS)的O-特异性多糖(OSP)定义的。我们对口服灭活霍乱疫苗(OCV WC-rBS)成年接种者的OSP特异性免疫反应进行了表征,并将其与霍乱弧菌O1小川型引起的霍乱患者的反应进行了比较。尽管接种疫苗者在接种后7天产生了针对小川型OSP和LPS的血浆免疫球蛋白G(IgG)、IgM、IgA抗体和抗体分泌细胞(ASC,黏膜反应标志物),但其反应明显低于霍乱后的反应。同样,从霍乱中康复的患者在第30天和第90天对OSP和LPS有可检测到的IgA、IgM和IgG记忆B细胞(MBC)反应,而接种疫苗者仅在第二次免疫后30天对OSP产生IgG反应。接种疫苗者中观察到的对OSP和LPS的ASC和MBC反应明显较低,这可能部分解释了与自然感染相比,OCV的保护作用较低的原因。